Haemodynamic and Geometric Factors in Atherosclerosis
ANGLE
Influence of Haemodynamic and Geometric Factors on the Onset and Progression of Atherosclerosis
1 other identifier
observational
100
1 country
1
Brief Summary
The study is a prospective-observational, explorative single-centre cohort study aimed to examine the influence of hemodynamic and geometric parameters on the progression of atherosclerotic alterations in peripheral vessels (carotids, femoral artery). Atherosclerotic alterations (IMT, plaque volume) will be measured with a ultrasound (IMT measurements and 3D quantitative plaque volumetry) and magnetic resonance imaging (MRI). Geometric parameters (e.g. carotid/femoral bifurcation angle, carotid/femoral bifurcation area) are assessed with magnetic resonance imaging (MRI) and also 3D ultrasonography. A total of 100 patients with an asymmetrical plaque distribution in carotid and femoral arteries will be tested. Only patients who are already enrolled in the "Correlation of Artherosclerotic Plaque Volume and Intima Media Thickness With Soluble P-selectin" (NCT01895725) and who are tested prior for an asymmetrical plaque distribution will be included in this study. MRI will be performed once whereas ultrasound imaging will be be repeated once per year (up to five times) to assess changes in these parameters over time. Also plasma samples will be collected once yearly and tested for traditional and novel cardiovascular risk factors. The primary endpoint of the planned study will be the correlation between geometrical and hemodynamic parameters as stated above and the progression of atherosclerosis as measured by plaque volume and IMT in the carotid and femoral arteries, respectively. Secondary endpoints will include the correlation of geometrical and hemodynamic parameters with established (hypertension, smoking, diabetes, dyslipidemia) and novel risk factors (hsCRP, P-selectin, cholesteryl ester transfer protein (CETP), intercellular adhesion molecule-1 (ICAM-1), CETP TaqIb polymorphism), with cardiovascular event rate, plaque localization, plaque morphology and the additional predictive value of geometrical parameters compared to an established risk score (SCORE card).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2017
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 31, 2017
CompletedStudy Start
First participant enrolled
February 6, 2017
CompletedFirst Posted
Study publicly available on registry
February 7, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 8, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2028
ExpectedMay 14, 2021
May 1, 2021
2.8 years
January 31, 2017
May 13, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Correlation between geometrical and hemodynamic parameters and the progression of atherosclerosis
Haemodynamic/geometric parameters will be assessed with MRI and 3D-US. This includes carotid/femoral bifurcation angle, common carotid/femoral area, carotid/femoral bifurcation area, internal and external carotid area, femoral superficial artery area and carotid/femoral bifurcation length. Progression of atherosclerosis will be measured via 3D-US by plaque volume and IMT in the carotid and femoral arteries, respectively.
up to 1 year
Secondary Outcomes (3)
Correlation of geometrical and hemodynamic parameters with established and novel risk factors.
up to 1 year
Correlation of geometrical and hemodynamic parameters with cardiovascular event rate
1 year
Correlation of geometrical and hemodynamic parameters with plaque morphology
up to 1 year
Eligibility Criteria
Only patients who are already enrolled in the "Correlation of Artherosclerotic Plaque Volume and Intima Media Thickness With Soluble P-selectin" (NCT01895725) and who are tested prior for an asymmetrical plaque distribution will be included in this study.
You may qualify if:
- asymmetrical (side difference) plaque distribution in carotids/femoral arteries which was tested in at least two prior 3D-ultrasound examinations (absolute side difference in carotid arteries ≥ 30 mm3 or in femoral arteries ≥50 mm3 and relative side difference in carotid arteries/femoral arteries ≥50% )
You may not qualify if:
- actual pregnancy, lactation period, chronic renal insufficiency (GFR\<20ml/min)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Medical University of Innsbruck
Innsbruck, Tyrol, 6020, Austria
Related Publications (1)
Schreinlechner M, Noflatscher M, Kremser C, Steiger R, Gromer J, Theurl M, Kirchmair R, Mayr A, Marschang P. A Large Bifurcation Angle Is Strongly Associated With Increased Plaque Volume and Plaque Progression. JACC Cardiovasc Imaging. 2019 Oct;12(10):2087-2088. doi: 10.1016/j.jcmg.2019.05.006. Epub 2019 Jun 12. No abstract available.
PMID: 31202757DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Peter Marschang, Prof., MD
Medical University Innsbruck
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Ao. Univ.Prof.Dr.
Study Record Dates
First Submitted
January 31, 2017
First Posted
February 7, 2017
Study Start
February 6, 2017
Primary Completion
November 8, 2019
Study Completion (Estimated)
January 1, 2028
Last Updated
May 14, 2021
Record last verified: 2021-05
Data Sharing
- IPD Sharing
- Will not share